interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Generic competition check › Canagliflozin; Metformin Hydrochloride

Generic competition · all medicines · read 12 November 2026

Is there a generic of Canagliflozin; Metformin Hydrochloride, and who makes it?

Canagliflozin; Metformin Hydrochloride appears in 2 dosage-form groups in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed. 2 groups have a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. This is the Orange Book's listing, not a forecast.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.
Canagliflozin; Metformin Hydrochloride2 dosage-form groups in the Orange Book
0generic makers listed
  1. Canagliflozin; Metformin Hydrochloride appears in 2 dosage-form groups in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed.
  2. 2 groups have a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
  3. Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

Tablet, Extended Release, Oral

Brand listed, no generic listed as marketed

Brand listed as marketed: Invokamet Xr. No generic is listed as marketed.

201520202025203001brand 2016data datePatent 7943788 listed to expire 14 July 2027Patent 8513202 listed to expire 3 December 2027Patent 7943788*PED listed to expire 14 January 2028Patent 8513202*PED listed to expire 3 June 2028Patent 7943582 listed to expire 26 February 2029Patent 7943582*PED listed to expire 26 August 2029Exclusivity NPP to 18 December 2027Exclusivity PED to 18 June 2028
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

  • 18 December 2027Exclusivity NPP Invokamet Xr
  • 18 June 2028Exclusivity PED Invokamet Xr
  • 14 July 2027Patent 7943788 drug substance
  • 3 December 2027Patent 8513202 drug substance
  • 14 January 2028Patent 7943788*PED
  • 3 June 2028Patent 8513202*PED
  • 26 February 2029Patent 7943582 drug substance
  • 26 August 2029Patent 7943582*PED

Tablet, Oral

Brand listed, no generic listed as marketed

Brand listed as marketed: Invokamet. No generic is listed as marketed.

2010201520202025203001brand 2014data datePatent 7943788 listed to expire 14 July 2027Patent 8513202 listed to expire 3 December 2027Patent 7943788*PED listed to expire 14 January 2028Patent 8513202*PED listed to expire 3 June 2028Patent 7943582 listed to expire 26 February 2029Patent 7943582*PED listed to expire 26 August 2029Patent 11576894 listed to expire 6 July 2030Exclusivity NPP to 18 December 2027Exclusivity PED to 18 June 2028
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

  • 18 December 2027Exclusivity NPP Invokamet
  • 18 June 2028Exclusivity PED Invokamet
  • 14 July 2027Patent 7943788 drug substance
  • 3 December 2027Patent 8513202 drug substance
  • 14 January 2028Patent 7943788*PED
  • 3 June 2028Patent 8513202*PED
  • 26 February 2029Patent 7943582 drug substance
  • 26 August 2029Patent 7943582*PED
  • 6 July 2030Patent 11576894 drug product

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.